The downgrade is a result of several factors, including the medical center’s diluted margin in fiscal year 2017, high leverage metrics and weak liquidity measures. Moody’s also acknowledged MaineGeneral’s strong market position and moderate capital spending plan.
The outlook is stable, reflecting Moody’s expectation that the medical center’s executive team will address challenges to improve operating performance and liquidity metrics.
More articles on healthcare finance:
Swedish Health’s Cherry Hill campus no longer at risk of losing Medicare funding
Missouri hospital’s Medicare contract no longer at risk
OIG: Replacement of 7 recalled and prematurely failed medical devices cost Medicare $1.5B over a decade
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
